• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白 C-II 和 C-III 更倾向于从极低密度脂蛋白 (VLDL) 转移到高密度脂蛋白 (HDL)2 和更大的 HDL3。

Apolipoprotein C-II and C-III preferably transfer to both high-density lipoprotein (HDL)2 and the larger HDL3 from very low-density lipoprotein (VLDL).

机构信息

Clinical Laboratory, Medical Hospital, Tokyo Medical and Dental University (TMDU), 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.

Analytical Laboratory Chemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.

出版信息

Biol Chem. 2021 May 26;402(4):439-449. doi: 10.1515/hsz-2020-0288. Epub 2020 Dec 18.

DOI:10.1515/hsz-2020-0288
PMID:33934596
Abstract

Triglyceride hydrolysis by lipoprotein lipase (LPL), regulated by apolipoproteins C-II (apoC-II) and C-III (apoC-III), is essential for maintaining normal lipid homeostasis. During triglyceride lipolysis, the apoCs are known to be transferred from very low-density lipoprotein (VLDL) to high-density lipoprotein (HDL), but the detailed mechanisms of this transfer remain unclear. In this study, we investigated the extent of the apoC transfers and their distribution in HDL subfractions, HDL2 and HDL3. Each HDL subfraction was incubated with VLDL or biotin-labeled VLDL, and apolipoproteins and lipids in the re-isolated HDL were quantified using western blotting and high-performance liquid chromatography (HPLC). In consequence, incubation with VLDL showed the increase of net amount of apoC-II and apoC-III in the HDL. HPLC analysis revealed that the biotin-labeled apolipoproteins, including apoCs and apolipoprotein E, were preferably transferred to the larger HDL3. No effect of cholesteryl ester transfer protein inhibitor on the apoC transfers was observed. Quantification of apoCs levels in HDL2 and HDL3 from healthy subjects (n = 8) showed large individual differences between apoC-II and apoC-III levels. These results suggest that both apoC-II and apoC-III transfer disproportionately from VLDL to HDL2 and the larger HDL3, and these transfers might be involved in individual triglyceride metabolism.

摘要

脂蛋白脂肪酶(LPL)水解甘油三酯,受载脂蛋白 C-II(apoC-II)和 C-III(apoC-III)调控,对于维持正常的脂质稳态至关重要。在甘油三酯脂肪分解过程中,已知 apoC 从极低密度脂蛋白(VLDL)转移到高密度脂蛋白(HDL),但这种转移的详细机制尚不清楚。在本研究中,我们研究了 apoC 转移的程度及其在 HDL 亚组分(HDL2 和 HDL3)中的分布。将每个 HDL 亚组分与 VLDL 或生物素标记的 VLDL 孵育,并使用 Western blot 和高效液相色谱(HPLC)定量回收的 HDL 中的载脂蛋白和脂质。结果表明,与 VLDL 孵育会增加 HDL 中 apoC-II 和 apoC-III 的净含量。HPLC 分析显示,生物素标记的载脂蛋白,包括 apoC 和载脂蛋白 E,优先转移到较大的 HDL3。胆固醇酯转移蛋白抑制剂对 apoC 转移没有影响。对 8 名健康受试者(n=8)的 HDL2 和 HDL3 中 apoCs 水平的定量分析显示,apoC-II 和 apoC-III 水平之间存在很大的个体差异。这些结果表明,apoC-II 和 apoC-III 均从 VLDL 不成比例地转移到 HDL2 和更大的 HDL3,并且这些转移可能与个体甘油三酯代谢有关。

相似文献

1
Apolipoprotein C-II and C-III preferably transfer to both high-density lipoprotein (HDL)2 and the larger HDL3 from very low-density lipoprotein (VLDL).载脂蛋白 C-II 和 C-III 更倾向于从极低密度脂蛋白 (VLDL) 转移到高密度脂蛋白 (HDL)2 和更大的 HDL3。
Biol Chem. 2021 May 26;402(4):439-449. doi: 10.1515/hsz-2020-0288. Epub 2020 Dec 18.
2
Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.人载脂蛋白 A-II 通过调节脂蛋白脂肪酶活性和高密度脂蛋白蛋白质组来决定血浆甘油三酯。
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):232-8. doi: 10.1161/ATVBAHA.109.198226. Epub 2009 Nov 12.
3
Effects of dietary carbohydrate and fat on plasma lipoproteins and apolipoproteins C-II and C-III in healthy men.膳食碳水化合物和脂肪对健康男性血浆脂蛋白及载脂蛋白C-II和C-III的影响。
J Lipid Res. 1982 Aug;23(6):877-86.
4
Fate of apolipoproteins C-1, C-iii, and E during lipolysis of human very low density lipoproteins in vitro.人极低密度脂蛋白体外脂解过程中载脂蛋白C-1、C-III和E的命运
J Lipid Res. 1981 May;22(4):641-51.
5
Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins.非平衡载脂蛋白C-II对脂蛋白脂肪酶的异常激活:血浆脂蛋白中存在非平衡载脂蛋白C-II和C-III池的进一步证据。
J Lipid Res. 1993 Oct;34(10):1793-803.
6
In vitro catabolism of human plasma very low density lipoproteins. Effects of VLDL concentration on the interconversion of high density lipoprotein subfractions.人血浆极低密度脂蛋白的体外分解代谢。极低密度脂蛋白浓度对高密度脂蛋白亚组分相互转化的影响。
Atherosclerosis. 1982 Feb;41(2-3):381-94. doi: 10.1016/0021-9150(82)90202-7.
7
Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.脂蛋白脂肪酶和肝脂肪酶对极低密度脂蛋白(VLDL)脂解过程中VLDL和高密度脂蛋白(HDL)转化的影响。
Atherosclerosis. 1995 Dec;118(2):193-212. doi: 10.1016/0021-9150(95)05606-8.
8
Dynamic properties of human high density lipoprotein apoproteins.人类高密度脂蛋白载脂蛋白的动态特性
J Lipid Res. 1978 Mar;19(3):383-9.
9
Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV.脂蛋白ApoC-II对脂蛋白脂肪酶的激活作用。载脂蛋白A-IV的调节作用。
J Biol Chem. 1990 Mar 15;265(8):4266-72.
10
Conversion of human plasma high density lipoprotein-2 to high density lipoprotein-3. Roles of neutral lipid exchange and triglyceride lipases.人血浆高密度脂蛋白2向高密度脂蛋白3的转化。中性脂质交换和甘油三酯脂肪酶的作用。
J Biol Chem. 1986 Apr 15;261(11):5201-8.

引用本文的文献

1
Efficacy and Safety of Olezarsen in Dyslipidemia: A Systematic Review and Dose-response Meta-analysis of Randomized Controlled Trials.奥雷扎森治疗血脂异常的疗效和安全性:随机对照试验的系统评价和剂量反应荟萃分析
J Saudi Heart Assoc. 2025 Jun 12;37(3):3. doi: 10.37616/2212-5043.1439. eCollection 2025.
2
The role of the farnesoid X receptor in diabetes and its complications.法尼醇X受体在糖尿病及其并发症中的作用。
Mol Cell Biochem. 2025 May;480(5):2725-2736. doi: 10.1007/s11010-024-05162-2. Epub 2024 Nov 22.
3
Triglyceride-rich lipoprotein, remnant cholesterol, and apolipoproteins CII, CIII, and E in patients with schizophrenia.
富含甘油三酯的脂蛋白、残胆固醇以及载脂蛋白 CII、CIII 和 E 在精神分裂症患者中的水平。
J Lipid Res. 2024 Jul;65(7):100577. doi: 10.1016/j.jlr.2024.100577. Epub 2024 Jun 13.
4
Associations of an HDL apolipoproteomic index with cardiometabolic risk factors before and after exercise training in the HERITAGE Family Study.载脂蛋白高密度脂蛋白组学指数与 HERITAGE 家族研究中运动训练前后心血管代谢危险因素的相关性。
Atherosclerosis. 2024 Aug;395:117587. doi: 10.1016/j.atherosclerosis.2024.117587. Epub 2024 May 17.
5
Multiplexed MRM-based proteomics for identification of circulating proteins as biomarkers of cardiovascular damage progression associated with diabetes mellitus.基于多重 MRM 的蛋白质组学鉴定与糖尿病相关的心血管损伤进展相关的循环蛋白作为生物标志物。
Cardiovasc Diabetol. 2024 Jan 20;23(1):36. doi: 10.1186/s12933-024-02125-1.
6
Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance.探索载脂蛋白 C-III:病理生理学和药理学相关性。
Cardiovasc Res. 2024 Feb 17;119(18):2843-2857. doi: 10.1093/cvr/cvad177.
7
APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism.载脂蛋白 C-III:控制甘油三酯代谢的守门员。
Curr Atheroscler Rep. 2023 Mar;25(3):67-76. doi: 10.1007/s11883-023-01080-8. Epub 2023 Jan 23.
8
Alterations of HDL's to piHDL's Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies.慢性炎症性疾病患者中高密度脂蛋白(HDL)向前β高密度脂蛋白(piHDL)蛋白质组的改变以及针对HDL的疗法
Pharmaceuticals (Basel). 2022 Oct 18;15(10):1278. doi: 10.3390/ph15101278.
9
The Differential Effects of HDL Subpopulations on Lipoprotein Lipase (LPL)-Mediated VLDL Catabolism.高密度脂蛋白亚群对脂蛋白脂肪酶(LPL)介导的极低密度脂蛋白分解代谢的差异影响。
Biomedicines. 2021 Dec 5;9(12):1839. doi: 10.3390/biomedicines9121839.